Table 1. Open in new tab Number of...

	Mutations	AmplificationTimeR	MutationTimeR	cancerTiming
1	All	107	78	85	59	39	27
2	SBS	86	54	75	52	29	19
3	C > T	78	43	70	49	26	15

	Mutations	AmplificationTimeR	MutationTimeR	cancerTiming
1	All	107	78	85	59	39	27
2	SBS	86	54	75	52	29	19
3	C > T	78	43	70	49	26	15

Table 1.

Number of samples for which at least one point was timed, out of a total of 156 BRCA and 102 OV samples featuring a gain of some sort.^a

	Mutations	AmplificationTimeR		MutationTimeR		cancerTiming
		BRCA	OV	BRCA	OV	BRCA	OV
1	All	107	78	85	59	39	27
2	SBS	86	54	75	52	29	19
3	C > T	78	43	70	49	26	15

	Mutations	AmplificationTimeR		MutationTimeR		cancerTiming
		BRCA	OV	BRCA	OV	BRCA	OV
1	All	107	78	85	59	39	27
2	SBS	86	54	75	52	29	19
3	C > T	78	43	70	49	26	15

Boldface indicates the highest number of samples timed for each combination of tools, tumour types, and mutation types. “SBS” indicates timing using only mutations attributed to mutational signatures SBS1 and SBS5. “C > T” indicates timing using only C > T mutations at CpG sites. “All” indicates the use of all available mutations for timing.

This Feature Is Available To Subscribers Only